Psychopharmacology
Andrew Penn, RN, MS, NP, PMHNP-BC
Associate Clinical Professor, School of Nursing, University of California, San Francisco, California
San Francisco, California
Clinicians are increasingly encountering patients using cannabis to treat their own symptoms, leaving many clinicians unsure how to proceed. The non-intoxicating cannabinoid cannabidiol (CBD) has received considerable acclaim in the popular press and among patients. This session will critically examine the evidence for the claims of anxiolytic, antidepressant, and antipsychotic benefits of CBD; explore what still needs to be studied and provide pragmatic advice for clinicians who are working with patients who are already using CBD.